Accord Innovates With Cancer Support App
Launches Unify Health App, Incorporating Information From Macmillan Cancer Support
Executive Summary
Accord Healthcare has launched an app to support cancer patients and help manage symptoms, incorporating expert data from Macmillan Cancer Support.
You may also be interested in...
Three Pillars Must Support Value Added Medicines In EU
Medicines for Europe has called for fresh efforts to bolster the value added medicines sector and “level the playing field” with the US and its 505(b)(2) pathway, launching a new report setting out the three key areas in which greater EU action is needed.
Accord Seeks To Capitalize On Portfolio And Partnerships
Accord expects to maintain its historically high growth rates through a “holistic” approach to medicines that covers generics and biosimilars alongside more innovative products, with recent marketing alliances in Europe playing into the firm’s ambitions in the CNS area.
Accord Rolls Out Zercepac Trastuzumab Biosimilar In UK
Accord has launched its first monoclonal antibody biosimilar and fourth biosimilar overall, introducing in the UK the Zercepac version of trastuzumab developed by China’s Shanghai Henlius Biotech.